Organogenesis In-Date & Expired
Organogenesis is a leading regenerative medicine company that specializes in the development and commercialization of advanced wound care and tissue repair products. The company's portfolio includes biologic therapies such as Apligraf, a living cell-based wound care product for chronic wounds, and Dermagraft, a decellularized human dermal substitute used for diabetic foot ulcers and other complex wounds. Organogenesis also offers Novachor, a wound care solution for chronic and non-healing wounds. The company's products are designed to promote healing, reduce complications, and improve the quality of life for patients suffering from chronic wounds, burn injuries, and soft tissue damage. With a strong emphasis on innovation, Organogenesis helps accelerate tissue regeneration and healing through biologic solutions.